Wellington Management Group
IMRX icon

Wellington Management Group’s Immuneering IMRX Stock Holding History

Wellington Management Group’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-156,424
Closed -$824K – 2000
2026
Q1 		$824K Buy
+156,424
New +$802K ﹤0.01% 1710

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Wellington Management Group's IMRX Position: Q2 2026 in Review

Wellington Management Group sold out of Immuneering (IMRX) in Q2 2026, closing a stake of 156,424 shares — an estimated $824K sold.

Wellington Management Group first reported a position in IMRX in Q1 2026 and held it in 1 quarter. The position peaked at $824K in Q1 2026. 112 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Wellington Management Group reported no remaining Immuneering position as of Q2 2026 after selling out during the quarter.
  • Wellington Management Group sold 156,424 Immuneering shares in Q2 2026, an estimated $824K.
  • Wellington Management Group first reported a position in Immuneering in Q1 2026 and held it in 1 quarter.
  • Wellington Management Group's Immuneering position peaked at $824K in Q1 2026.
  • 112 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.